Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$647K Buy
3,507
+240
+7% +$42.5K 0.29% 76
2018
Q1
$557K Sell
3,267
-50
-2% -$9.18K 0.25% 80
2017
Q4
$577K Buy
3,317
+140
+4% +$24.8K 0.19% 92
2017
Q3
$592K Hold
3,177
0.21% 89
2017
Q2
$547K Sell
3,177
-50
-2% -$8.13K 0.2% 86
2017
Q1
$529K Sell
3,227
-150
-4% -$24.9K 0.2% 90
2016
Q4
$494K Sell
3,377
-615
-15% -$92.6K 0.2% 92
2016
Q3
$666K Hold
3,992
0.27% 84
2016
Q2
$607K Hold
3,992
0.26% 86
2016
Q1
$599K Buy
3,992
+100
+3% +$14.9K 0.24% 86
2015
Q4
$632K Sell
3,892
-50
-1% -$7.86K 0.25% 88
2015
Q3
$545K Hold
3,942
0.24% 89
2015
Q2
$605K Hold
3,942
0.23% 93
2015
Q1
$630K Buy
3,942
+97
+3% +$15.3K 0.24% 91
2014
Q4
$612K Hold
3,845
0.23% 89
2014
Q3
$540K Hold
3,845
0.21% 95
2014
Q2
$455K Buy
3,845
+515
+15% +$59.6K 0.17% 100
2014
Q1
$411K Buy
3,330
+100
+3% +$12.1K 0.16% 103
2013
Q4
$368K Hold
3,230
0.15% 105
2013
Q3
$362K Hold
3,230
0.15% 103
2013
Q2
$319K Buy
+3,230
New +$335K 0.15% 110

Other funds holding AMGN

Outfitter Advisors's AMGN Position: Q2 2018 in Review

Outfitter Advisors increased its Amgen (AMGN) stake by 7.3% in Q2 2018, buying an estimated $42.5K and bringing the position to 3,507 shares worth $647K. The position accounts for 0.29% of the portfolio, ranked #76.

Outfitter Advisors first reported a position in AMGN in Q2 2013 and has held it in 21 quarters since. The position peaked at $666K in Q3 2016. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Outfitter Advisors held 3,507 shares of Amgen worth $647K as of Q2 2018.
  • Outfitter Advisors bought 240 Amgen shares in Q2 2018, an estimated $42.5K.
  • Amgen made up 0.29% of Outfitter Advisors's portfolio in Q2 2018, its #76 holding.
  • Outfitter Advisors first reported a position in Amgen in Q2 2013 and has held it in 21 quarters since.
  • Outfitter Advisors's Amgen position peaked at $666K in Q3 2016.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Outfitter Advisors's 13F filing for Q2 2018, filed 23 Jul 2018.